Quad Technologies

Quad Technologies is a life sciences company that develops innovative cell separation and activation tools designed to streamline the manufacturing of cell and gene therapies. The company's proprietary QuickRelease hydrogel technology enables the isolation of specific cell populations, such as T-cells, with high purity and viability by allowing for the gentle release of captured cells. Their primary product line, MagCloudz, provides a scalable solution for researchers and clinicians to perform cell processing without the limitations of traditional magnetic bead technologies. Following its acquisition by Bio-Techne in 2018, Quad Technologies' platform has been integrated into a broader suite of bioprocessing solutions aimed at accelerating the development of advanced medicines.